-transparent.png){kind=logo}
The results of a clinical trial on both tolerance and therapeutic effect of ACTA (Arginine-Thiazolidine-Carboxylate) are reported. Thirty patients were treated wih the drug according to a standard administration scheme: 1,2 g of Arginine-Thiazolidine-Carboxylate per day for 60 days. Statistical evaluation has shown, in comparison with the basal values, highly significant differences at the end of the treatment for the parameters of the so-called "cytolytic syndrome". The concept of membrane-protecting action against lipo-peroxydation, exerted by ATCA is also confirmed by the ultra-structural pictures obtained from bioptic liver specimens.
Related Publications
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
January 1977,
Clinical chemistry,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
May 1982,
Il Farmaco; edizione pratica,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
January 1982,
Minerva dietologica e gastroenterologica,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
January 1979,
Minerva dietologica e gastroenterologica,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
October 1980,
Lancet (London, England),
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
January 1968,
Digestion,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
March 1953,
Medicinski glasnik,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
February 1965,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
January 1967,
Roczniki Akademii Medycznej im. Juliana Marchlewskiego w Bialymstoku,
V Alvisĭ, and
A D'Ambrosi, and
A Lo Ponte, and
M L Tampieri, and
M Tralli
June 2001,
Current microbiology,
